Upexi, a consumer products company specializing in medicinal mushrooms and caffeine alternatives, experienced a significant stock decline of 98.02% from April 2020 to early April 2025. However, on April 21, the company announced the implementation of a new sol treasury strategy, which led to a sharp increase in its stock price. This development raises questions about whether crypto treasury executives might benefit financially from the stock surge and if shareholders could potentially be disadvantaged.